Morton Brown Family Wealth’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$39.3K Buy
156
+42
+37% +$9.04K 0.01% 134
2026
Q1
$24.8K Hold
114
0.01% 143
2025
Q4
$26K Buy
114
+14
+14% +$3.19K 0.01% 138
2025
Q3
$23.2K Hold
100
0.01% 135
2025
Q2
$18.6K Hold
100
0.01% 147
2025
Q1
$21K Buy
+100
New +$19.4K 0.01% 143
2024
Q4
Sell
-100
Closed -$19.7K 284
2024
Q3
$19.7K Buy
+100
New +$18.7K 0.01% 134
2024
Q1
Sell
-104
Closed -$16.1K 217
2023
Q4
$16.1K Buy
+104
New +$15.2K 0.01% 156
2022
Q4
Sell
-34
Closed -$5K 158
2022
Q3
$5K Buy
34
+24
+240% +$3.44K ﹤0.01% 139
2022
Q2
$2K Buy
+10
New +$1.53K ﹤0.01% 187

Other funds holding ABBV

Morton Brown Family Wealth's ABBV Position: Q2 2026 in Review

Morton Brown Family Wealth increased its AbbVie (ABBV) stake by 37% in Q2 2026, buying an estimated $9.04K and bringing the position to 156 shares worth $39.3K. The position accounts for 0.01% of the portfolio, ranked #134.

Morton Brown Family Wealth first reported a position in ABBV in Q2 2022 and has held it in 10 quarters since. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Morton Brown Family Wealth held 156 shares of AbbVie worth $39.3K as of Q2 2026.
  • Morton Brown Family Wealth bought 42 AbbVie shares in Q2 2026, an estimated $9.04K.
  • AbbVie made up 0.01% of Morton Brown Family Wealth's portfolio in Q2 2026, its #134 holding.
  • Morton Brown Family Wealth first reported a position in AbbVie in Q2 2022 and has held it in 10 quarters since.
  • 2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Morton Brown Family Wealth's 13F filing for Q2 2026, filed 21 Jul 2026.